{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:56:14Z","timestamp":1717876574596},"reference-count":20,"publisher":"Japanese Association of Virology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2015]]},"DOI":"10.2222\/jsv.65.263","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T22:06:46Z","timestamp":1476828406000},"page":"263-268","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis C virus-induced glucose metabolic disorder"],"prefix":"10.2222","volume":"65","author":[{"given":"Ikuo","family":"SHOJI","sequence":"first","affiliation":[{"name":"Division of Infectious Disease Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"DENG","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"MATSUI","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Center for Infectious Diseases, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak","family":"HOTTA","sequence":"additional","affiliation":[{"name":"Department of Oral Vaccine and Drug Development, Kobe University Graduate School of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gill K, Ghazinian H, Manch R, Gish R. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int. 2015 [Epub ahead of print].","DOI":"10.1007\/s12072-015-9684-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 29: 328-33, 1999.","DOI":"10.1002\/hep.510290235"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology. 38: 50-6, 2003.","DOI":"10.1053\/jhep.2003.50291"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol. 15: 1537-47, 2009.","DOI":"10.3748\/wjg.15.1537"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Negro F. Mechanisms of hepatitis C virus-related insulin resistance. Clin Res Hepatol Gastroenterol. 35: 358-63, 2011.","DOI":"10.1016\/j.clinre.2011.01.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Arase Y, Kobayashi M, Suzuki F, Suzuki Y, Kawamura Y, Akuta N, et al. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology. 57: 964-73, 2013.","DOI":"10.1002\/hep.26087"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 126: 840-8, 2004.","DOI":"10.1053\/j.gastro.2003.11.056"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Miyamoto H, Moriishi K, Moriya K, Murata S, Tanaka K, Suzuki T, et al. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol. 81: 1727-35, 2007.","DOI":"10.1128\/JVI.01683-06"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, Jiang DP, et al. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol. 85: 8556-68, 2011.","DOI":"10.1128\/JVI.00146-11"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shoji I, Deng L, Hotta H. Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders. Frontiers in microbiology. 2: 278, 2011.","DOI":"10.3389\/fmicb.2011.00278"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kasai D, Adachi T, Deng L, Nagano-Fujii M, Sada K, Ikeda M, et al. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol. 50: 883-94, 2009.","DOI":"10.1016\/j.jhep.2008.12.029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Matsui C, Shoji I, Kaneda S, Sianipar IR, Deng L, Hotta H. Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1alpha. J Virol. 86: 12903-11, 2012.","DOI":"10.1128\/JVI.01418-12"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Matsui C, Sianipar IR, Minami N, Deng L, Hotta H, Shoji I. A single-amino-acid mutation in hepatitis C virus NS5A disrupts physical and functional interaction with the transcription factor HNF-1alpha. J Gen Virol. 96: 2200-5, 2015.","DOI":"10.1099\/vir.0.000179"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes. 49: 969-74, 2000.","DOI":"10.2337\/diabetes.49.6.969"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ogawa W, Kasuga M. Cell signaling. Fat stress and liver resistance. Science. 322: 1483-4, 2008.","DOI":"10.1126\/science.1167571"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 202: 654-62, 2005.","DOI":"10.1002\/jcp.20166"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Armendariz AD, Krauss RM. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol. 20: 106-11, 2009.","DOI":"10.1097\/MOL.0b013e3283295ee9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384: 455-8, 1996.","DOI":"10.1038\/384455a0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Okamoto T, Nishimura Y, Ichimura T, Suzuki K, Miyamura T, Suzuki T, et al. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. The EMBO journal. 25: 5015-25, 2006.","DOI":"10.1038\/sj.emboj.7601367"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, et al. A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol. 82: 3480-9, 2008.","DOI":"10.1128\/JVI.02253-07"}],"container-title":["Uirusu"],"original-title":["C\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u306b\u3088\u308b\u7cd6\u4ee3\u8b1d\u7570\u5e38"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/65\/2\/65_263\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T19:16:51Z","timestamp":1568488611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/65\/2\/65_263\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.65.263","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}